Presenter: Dr. Michael Allan James McCormack BSc(Pharm) PharmD Samantha Moe PharmD
In episode 593, Mike and James invite Samantha Moe back to talk about a newer agent for osteoporosis. So, if you want to know all the evidence for romosozumab, tune in and all will be revealed about the benefits and harms. Show notes 1) Tools for Practice Tony Romo-sozumab: Winning touchdown in osteoporosis or interception…
Latest Podcasts
In the Clinic Episode 42: Lower Urinary Tract Symptoms
In this episode of In the Clinic, Mike and Jess invite back Dr. Émélie Braschi. The team discusses Per Colate, a 72-year-old male coming in for lower urinary tract symptoms To earn…
In the Clinic Episode 41: Prenatal Screening for Fetal Anomalies
In this episode of In the Clinic, Mike and Jess invite back Dr. Jennifer Young. The team discusses Annie Ploidy, a 36-year-old female coming in for prenatal screening. To earn an additional…
FM Rounds #18: Inclusive by Default: From Minority Stress to Trauma-Informed Primary Care
Over 60% of Canadian trans adults rate their mental health as fair-to-poor and are twice as likely to avoid seeking primary care. Avoidance isn’t random – it’s the predictable outcome…
February 5, 2025
Presenter(s):
Dr. Michael Allan James McCormack BSc(Pharm) PharmD Samantha Moe PharmD
Please provide any additional comments (optional).